Literature DB >> 11053702

Comparison of percutaneous interventions for unstable angina pectoris in patients with and without previous coronary artery bypass grafting.

V Mathew1, P B Berger, R J Lennon, B J Gersh, D R Holmes.   

Abstract

An increasing number of patients who have undergone previous coronary artery bypass grafting (CABG) are referred for percutaneous coronary revascularization. We identified patients who underwent percutaneous intervention for unstable angina from 1990 to 1998 at our institution and assigned them into 2 groups based on whether or not they had undergone previous CABG. There were 1,431 patients with and 4,629 patients without previous CABG. Previous CABG patients were older, had more atherosclerotic risk factors, more heart failure, lower ejection fraction, more multivessel disease, more multilesion treatment, more complex lesions, and less complete revascularization. Adjusting for baseline differences, previous CABG was associated with worse long-term mortality (RR 1.47, 95% confidence intervals [CI] 1.22 to 1.77, p < 0.001) and death, myocardial infarction, and/or revascularization (RR 1.16, 95% CI 1.04 to 1.30, p = 0.01); treatment of native lesions in patients with previous CABG versus treatment of vein graft lesions was associated with a reduction in this composite end point (RR 0.75, 95% CI 0.65 to 0.87, p < 0.001). Post-CABG patients treated between 1995 and 1998 had lower long-term mortality (RR 0.76, 95% CI 0.59 to 0.99, p = 0.04) and death, myocardial infarction, and/or revascularization (RR 0.76, 95% CI 0.66 to 0.88, p < 0.001) compared with those treated between 1990 and 1994. Thus, in patients with unstable angina referred for percutaneous revascularization, previous CABG is associated with reduced event-free survival, although the outcome of post-CABG patients treated from 1995 to 1998 is superior to that observed in patients treated from 1990 to 1994. In patients who underwent previous CABG, treatment of native lesions affords better long-term outcome than vein graft intervention.

Entities:  

Mesh:

Year:  2000        PMID: 11053702     DOI: 10.1016/s0002-9149(00)01125-5

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  4 in total

1.  Real-world experience of drug-eluting stents in saphenous vein grafts compared to native coronary arteries: results from the prospective multicenter German DES.DE registry.

Authors:  Ibrahim Akin; Marcus Wiemer; Steffen Schneider; Jochen Senges; Matthias Hochadel; Gert Richardt; Mohamed Abdel-Wahab; Karl-Heinz Kuck; Christoph A Nienaber
Journal:  Clin Res Cardiol       Date:  2011-11-13       Impact factor: 5.460

2.  Early vs Late Coronary Angiography and Intervention Following Thrombolytic Therapy; a Cohort Study.

Authors:  Bahareh Feizi; Shahram Taghdisi; Jalil Etemadi; Amir Hossein Feizi; Setareh Asgarzadeh; Sepideh Kamal
Journal:  Emerg (Tehran)       Date:  2017-01-11

3.  Prior Coronary Artery Bypass Graft Surgery and Outcome After Percutaneous Coronary Intervention: An Observational Study From the Pan-London Percutaneous Coronary Intervention Registry.

Authors:  Krishnaraj S Rathod; Anne-Marie Beirne; Richard Bogle; Sam Firoozi; Pitt Lim; Jonathan Hill; Miles C Dalby; Ajay K Jain; Iqbal S Malik; Anthony Mathur; Sundeep Singh Kalra; Ranil DeSilva; Simon Redwood; Philip A MacCarthy; Andrew Wragg; Elliot J Smith; Daniel A Jones
Journal:  J Am Heart Assoc       Date:  2020-06-01       Impact factor: 5.501

4.  Immediate results and six-month clinical outcome after percutaneous coronary intervention in patients with prior coronary artery bypass surgery.

Authors:  Fatemeh Behboudi; Hossein Vakili; Seyed Reza Hashemi; Manouchehr Hekmat; Morteza Safi; Mohammad Hasan Namazi
Journal:  J Tehran Heart Cent       Date:  2011-02-28
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.